Varian Medical Systems (VAR) Misses Q1 EPS by 1c, Revenues Beat; Offers FY19 EPS/Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/3/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- Equities close higher as softer jobs data quiets rate-hike expectations
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Varian Reports Results for First Quarter of Fiscal Year 2019
January 23, 2019 4:06 PM ESTPALO ALTO, Calif., Jan. 23, 2019 /PRNewswire/ --
First Quarter 2019 Summary      Oncology gross orders grew 16% in dollars, or 17% in constant currency      Total company revenues grew 9% in dollars, or 10% in constant currency, to $741 million      GAAP operating earnings grew 11% at 18.2% of revenues; Non-GAAP operating earnings declined 5% at 16.2% of revenues      GAAP net earnings per diluted share of $1.12; Non-GAAP net earnings per diluted share of $1.06      Recently enacted US/China tariffs negatively impacted revenues by $8 million and operating earnings by $11 million, generally in line with company expectations      Reaffirming fiscal year 2019 guidance of Non-GAAP net earnings... More
